1. Home
  2. UIS vs FHTX Comparison

UIS vs FHTX Comparison

Compare UIS & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unisys Corporation New

UIS

Unisys Corporation New

SELL

Current Price

$2.21

Market Cap

208.5M

Sector

Technology

ML Signal

SELL

Logo Foghorn Therapeutics Inc.

FHTX

Foghorn Therapeutics Inc.

HOLD

Current Price

$1.97

Market Cap

173.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UIS
FHTX
Founded
1942
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.5M
173.4M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
UIS
FHTX
Price
$2.21
$1.97
Analyst Decision
Buy
Buy
Analyst Count
4
10
Target Price
$4.81
★ $6.00
AVG Volume (30 Days)
587.8K
★ 1.1M
Earning Date
11-04-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 25.32
EPS
N/A
★ N/A
Revenue
★ $1,950,100,000.00
$30,909,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.84
$15.98
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 36.75
52 Week Low
$1.97
$1.79
52 Week High
$4.98
$7.61

Technical Indicators

Market Signals
Indicator
UIS
FHTX
Relative Strength Index (RSI) 32.99 15.98
Support Level $2.14 $1.79
Resistance Level $2.61 $5.35
Average True Range (ATR) 0.09 0.29
MACD 0.01 -0.08
Stochastic Oscillator 13.55 7.23

Price Performance

Historical Comparison
UIS
FHTX

About UIS Unisys Corporation New

Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides workplace solutions featuring intelligent workplace services, proactive experience management and collaboration tools to support business growth. CA&I which provides digital transformation in the areas of cloud migration and management. ECS which provides solutions that harness secure, high-intensity enterprise computing and enable digital services through software-defined operating environments. maximum of revenue is from CA&I segment.

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.

Share on Social Networks: